Lazanda Approved for Cancer Pain (HealthDay)

Admin

Administrator
Staff member
HealthDay - FRIDAY, July 1 (HealthDay News) -- Lazanda (fentanyl) nasal spray has been approved by the U.S. Food and Drug Administration to treat breakthrough pain in adults with cancer who are already receiving opioid therapy, drug maker Archimedes Pharma said.

More...
 
Top